Tag Archive for PRO/EDR> Zika virus (06): Americas, Pacific, Asia, Africa, research
PRO/EDR> Zika virus (06): Americas, Pacific, Asia, Africa, research
Zika virus -- Worldwide/UnknownVaccinations have begun in a multi-site Phase 2/2b clinical trial testing an experimental DNA vaccine designed to protect against disease caused by Zika infection. The vaccine was developed by government scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). NIAID is leading the trial, which aims to enroll at least 2490 healthy participants in areas of confirmed or potential active mosquito-transmitted Read more [...]
